Format

Send to

Choose Destination
See comment in PubMed Commons below
Addiction. 2011 Oct;106(10):1835-45. doi: 10.1111/j.1360-0443.2011.03495.x. Epub 2011 Aug 18.

The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.

Author information

  • 1SRI International, Menlo Park, CA 94025, USA. harold.javitz@sri.com

Abstract

AIMS:

To examine person-specific urge-to-smoke trajectories during the first 7 days of abstinence and the relationship of trajectory parameters to continuous abstinence, demographics, medication and smoking history.

DESIGN:

Hierarchical linear modeling was used to model person-specific trajectories for urge-to-smoke.

SETTING:

Two university-based smoking cessation trials.

PARTICIPANTS:

Treatment-seeking smokers in a clinical trial of transdermal nicotine (n = 275) versus nicotine spray (n = 239) and of bupropion (n = 223) versus placebo (n = 198).

MEASUREMENTS:

Self-reported urge-to-smoke for 7 days after the planned quit date, and 7-day point prevalence and continuous abstinence at end of treatment (EOT) and 6 months.

FINDINGS:

Urge-to-smoke trajectory parameters (average level, slope, curvature and volatility) varied substantially among individuals, had modest intercorrelations and predicted continuous and point prevalence abstinence at EOT and at 6 months. Higher trajectory level, slope and volatility were all significantly (P ≤ 0.001) associated with a reduced likelihood of abstinence at EOT (odds ratios 0.44-0.75) and at 6-month follow-up (odds ratios from 0.63 to 0.78), controlling for demographic, medication and smoking use variables.

CONCLUSION:

Higher urge-to-smoke trajectory parameters of level, slope and volatility (measured over 7 days) predict continuous and 7-day point prevalence at EOT and 6 months. Although there were some associations of trajectory parameters with demographics and smoking history, the associations of trajectory parameters with relapse were relatively uninfluenced by demographics and smoking history.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center